Authors' response.
作者信息
Chatterjee Pranab, Anand Tanu, Singh Kh Jitenkumar, Rasaily Reeta, Singh Ravinder, Das Santasabuj, Singh Harpreet, Praharaj Ira, Gangakhedkar Raman R, Bhargava Balram, Panda Samiran
机构信息
Translational Global Health Policy Research Cell, New Delhi, India.
Multidisciplinary Research Unit/Model Rural Health Research Unit, New Delhi, India.
出版信息
Indian J Med Res. 2020;152(1 & 2):122-123. doi: 10.4103/0971-5916.290075.
Abstract
摘要
相似文献
1
Authors' response.
Indian J Med Res. 2020;152(1 & 2):122-123. doi: 10.4103/0971-5916.290075.
2
Authors' response.
Indian J Med Res. 2020;152(1 & 2):125-126. doi: 10.4103/0971-5916.292028.
3
Authors' response.
Indian J Med Res. 2020;152(1 & 2):128-129. doi: 10.4103/0971-5916.291401.
4
Authors' response.
Indian J Med Res. 2020;152(1 & 2):144-145. doi: 10.4103/0971-5916.291398.
5
Authors' response.
Indian J Med Res. 2020;152(1 & 2):141. doi: 10.4103/0971-5916.291338.
6
Authors' response.
Indian J Med Res. 2020;152(1 & 2):117-118. doi: 10.4103/0971-5916.290527.
7
Authors' response.
Indian J Med Res. 2020;152(1 & 2):120. doi: 10.4103/0971-5916.290073.
8
Authors' response.
Indian J Med Res. 2020;152(1 & 2):147-148. doi: 10.4103/0971-5916.292093.
9
Authors' response.
Indian J Med Res. 2020;152(1 & 2):132-133. doi: 10.4103/0971-5916.292371.
10
Authors' response.
Indian J Med Res. 2020;152(1 & 2):135-136. doi: 10.4103/0971-5916.291340.
本文引用的文献
1
False reassurance or inadequate drug levels?
Indian J Med Res. 2020;152(1 & 2):121-123. doi: 10.4103/ijmr.IJMR_2485_20.
2
Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19.
Indian J Med Res. 2020 May;151(5):459-467. doi: 10.4103/ijmr.IJMR_2234_20.
3
Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.
Lancet Respir Med. 2020 Jul;8(7):687-695. doi: 10.1016/S2213-2600(20)30193-4. Epub 2020 May 7.
4
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237.
5
Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway.
J Virol. 2011 Oct;85(20):10582-97. doi: 10.1128/JVI.00671-11. Epub 2011 Jul 20.
Zotero 插件